News
UAE
Gulf
MENA
US
UK
Europe
Asia
Business
Aviation
Economy
Energy
Money
Property
Banking
Markets
Opinion
Comment
Editorial
Obituaries
Cartoon
Feedback
Future
Science
Space
Technology
Climate
Cop28
Environment
Road to Net Zero
Health
Culture
Art & Design
Books
Film & TV
Music & On-stage
Pop Culture
Lifestyle
Travel
Fashion & Beauty
Food
Motoring
Luxury
Home & Garden
Wellbeing
Things to do
Sport
Football
Cricket
Olympics
F1
Tennis
Combat Sports
Horse Racing
Arab Showcase
Weekend
Podcasts Newsletters Follow us Alerts App Video
Arab ShowcaseWeekend
News
UAE
Gulf
MENA
US
UK
Europe
Asia
Business
Aviation
Economy
Energy
Money
Property
Banking
Markets
Opinion
Comment
Editorial
Obituaries
Cartoon
Feedback
Future
Science
Space
Technology
Climate
Cop28
Environment
Road to Net Zero
Health
Culture
Art & Design
Books
Film & TV
Music & On-stage
Pop Culture
Lifestyle
Travel
Fashion & Beauty
Food
Motoring
Luxury
Home & Garden
Wellbeing
Things to do
Sport
Football
Cricket
Olympics
F1
Tennis
Combat Sports
Horse Racing
News
UAE
Gulf
MENA
US
UK
Europe
Asia
Business
Aviation
Economy
Energy
Money
Property
Banking
Markets
Opinion
Comment
Editorial
Obituaries
Cartoon
Feedback
Future
Science
Space
Technology
Climate
Cop28
Environment
Road to Net Zero
Health
Culture
Art & Design
Books
Film & TV
Music & On-stage
Pop Culture
Lifestyle
Travel
Fashion & Beauty
Food
Motoring
Luxury
Home & Garden
Wellbeing
Things to do
Sport
Football
Cricket
Olympics
F1
Tennis
Combat Sports
Horse Racing
Andrey Zarur

Andrey Zarur

Contributor
Andrey Zarur is chief executive and co-founder of GreenLight Biosciences, a biotech company
Follow on

Articles

A shot of the AstraZeneca vaccine is administered at the Ndirande Health Centre in Blantyre Malawi, on March 29. AP
Africa needs to be self-reliant in vaccine production for the world to recover from the pandemic

We must find a way to make enough vaccines, about 15 billion doses

April 17, 2021